CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
Odonate Therapeutics, Inc.  (ODT)
Other Ticker:  
 
 
Price: $22.3700 $0.05 0.224%
Day's High: $23.3 Week Perf: 0.13 %
Day's Low: $ 21.87 30 Day Perf: 4.53 %
Volume (M): 63 52 Wk High: $ 28.57
Volume (M$): $ 1,416 52 Wk Avg: $19.30
Open: $22.16 52 Wk Low: $11.54



 Market Capitalization (Millions $) 552
 Shares Outstanding (Millions) 25
 Employees 10
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -117
 Cash Flow (TTM) (Millions $) -0
 Capital Exp. (TTM) (Millions $) 2

Odonate Therapeutics, Inc.

We were incorporated in the State of Nevada on November 16, 2009 under the name “Online Disruptive Technologies, Inc.” with authorized capital of 500,000,000 shares of common stock with a par value of $0.001 per share and 20,000,000 shares of preferred stock with a par value of $0.001 per share. On March 24, 2010, we entered into a share purchase agreement with Benjamin Cherniak, whereby we acquired all of the issued and outstanding shares of RelationshipScoreboard.com Entertainment, Inc. (“RSE”) in consideration for the issuance of 16,000,000 of our common shares. RSE was incorporated in the State of Nevada on November 16, 2009. There were no related party interests in the acquisition of RSE.

The Savicell™ platform is a blood test designed for the early detection of disease. It is a broad platform with applications for cancer, autoimmune diseases, and infectious diseases. While our focus initially is on early diagnosis of disease, we believe our technology may have additional applications in drug response monitoring for therapies that impact immune response. Immunotherapy, both for treating cancer and autoimmune diseases, is an example where metabolic shift profiles could indicate response to drug treatment.

Initially, Savicell is focused on the multibillion-dollar cancer diagnosis market. Savicell deploys Well-Shield™ technology, a Liquid ImmunoBiopsy™ diagnostic platform. In contrast to existing technologies that evaluate secretions of cancer cells, Well-Shield’s ImmunoBiopsy platform receives data directly from the immune system. Importantly, Well-Shield is different in that it is a functional test measuring the metabolic activation profile of the immune system as an indicator of disease status. As an immune system test, it is inherently suited for early detection.

The technology has now received intellectual property protection with a patent approved in the United States, China, Japan and Europe. Furthermore, the patent process is ongoing in several other countries.

Disease intrusion and cell malformation, including cancer, are first detected by the immune system, which energizes to rid the body of the malignancy. The initial immune response to disease is intricate, deploying different metabolic pathways and subtypes of cells. The Well-ShieldTM technology is designed to detect and interpret these differential metabolic responses.



ODT is expected to report next financial results on August 14, 2019.
 

Vanjia Corp

Sales and Earnings Unchanged

In the first quarter Vanjia Corp reached break-even of $0.00 per share compare to $0.00 a year ago and from $-0.00 per share from the previous quarter.

Sales remained unchanged to $0.02 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.

Judo Capital Corp.

Revenues and Earnings Unchanged

In the first quarter reached break-even of $0.00 per share compare to $-0.00 a year ago and from $0.00 per share from the previous quarter.

Revenues remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.

Spindletop Oil & Gas Co

A $0.13 million tax benefit, helped Spindletop Oil & Gas Co to post $0.00 eps in the first quarter

A $0.13 million tax benefit, helped Spindletop Oil & Gas Co to post $0.00 eps in the first quarter

Newgioco Group, Inc.

Losses Widen, Sales are Up

Newgioco Group, Inc announced earnings per share of $-0.04 and Sales of $9.34 millions in the first quarter, Company's posted loss per share, versus $0.01 eps, earned in the same quarter a year ago, although Newgioco Group, Inc saw it's Sales rise by 7.82 % in the same period.

National Holdings Corp

Losses Widen, Sales Faded

Weak demand caused increase in losses for the second quarter, company's loss per share grew to $-0.22 from $-0.18 where Sales fell by -22.61 % to $46.70 millions from $60.35 millions a year ago.






   
Major Competitors Stock performance

5 Days Decrease / Increase
     
• View Complete Report
   



             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SNBP's Profile

Stock Price

SNBP's Financials

Business Description

Fundamentals

Charts & Quotes

SNBP's News

Suppliers

SNBP's Competitors

Customers & Markets

Economic Indicators

SNBP's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071